Ann: Fondaparinux Investor Update , page-7

Medicaid is much like our PBS - Pharmaceutical Benefits Scheme.

It costs a drug company to get their drug onto the list, but it will help to grow the volume, even allowing for the fact that the drug is discounted for those on some form of benefit.

Also, regarding the latest figures being down on the previous quarter, we need to take a closer look (perhaps at the previous Arixtra quarterly patterns) - drug purchases can sometimes be seasonal, depending upon purchasing patterns of wholesalers, hospitals etc.

The great thing for us is that volume keeps increasing and we have regular income rolling in - many companies would be wishing to be where we are and for me, the X factor is the potential for an HA deal 'real soon now'...!!